Thursday 29 September 2011

Spreading Awareness Strengthens Your Clinical Trial

Clinical trial is the effective methodology to bring out the usage of effective medication to improve the human health care. The present clinical trial is hurdled by many challenges and lack of proper awareness by the public is one among them. The misconception that is spread in the society about the Clinical trial is keeping the volunteers far from the participation which is in turn contributing to the financial expenditure. The reasons that strengthen the escapism of volunteers in the medical trial is lack availability of the fair treatment, fear of being harmed with the unproven treatment and few may not be able to give an active participation in spite of their interest due to ineligibility.

Clinical trials do have an inclusion and exclusion criteria, not everybody that reach the research center will be the volunteer in the medical trial. The experts will conduct through examining in order to give the approval for the participation. The health condition of the patient will be continuously monitored by the group of experts, so the chance of facing the health risk is completely minimized. It is recommended to spread the awareness of drug trial in the society to encourage volunteer participation. 

What is Placebo in The Clinical Trial?

The term placebo is not that peculiar to understand as it sounds. It is just a method implemented in the clinical trials to get effective results. The volunteers in the research study will be divided into two groups (more if required) on random selection, few are given the active treatment and the second group is given an in active treatment which is known as placebo. The names of the volunteers who receive the placebo are kept undisclosed from the participants, researches and the doctors. This would help the experts come up with the unbiased report about the medical observation. There is another type of placebo called sham procedure which replicates the active treatment but does not hold any qualities of it.

The participants in the clinical trial should be differentiated with the reactions from the drug treatment and nothing else.  The in convenience faced by the participant in the clinical trial should nothing more than the effects of the specified drug usage.

Wednesday 28 September 2011

Ethics of the Clinical Trial


Clinical trials though essential to the medical world should fallow some ethics to continue their progress. The medical trial should be designed with the social value. It needs to answer the significant question that adds value to the society. The answer provided the research team should justify asking people to accept certain risks for others. The study should be designed with clear scientific objective valid and feasible methods. The study should be directed towards the clear objective using accepted principals and methods and reliable practices.

There should be a right mix of the volunteers in the study to make the outcome work in the reality. Favorable risk benefit ratio should be established in the study and the benefits enjoyed by the volunteer should outweigh the risks handled by the volunteers. The study should be ethically accepted by the independent review committee before its commencement. Informed consent should be obtained from the participants of the study before they undergo the clinical trial. The privacy of the participants in the clinical trial should be highly protected.

Independent Safety Monitoring Committee Valuable Asset For The Drug Trials Conducted With The Children

It is accepted fact that Clinical trials are essential for the medical world to come out with the improved medical therapies to treat the new diseases that are killing the world. In spite of the huge benefits offered by the drug trails, they carry the blame of risk and unethical.

To skip the blame the sponsor has to appoint an independent review committee who can examine the data and fore cast the anticipated results and question the team of experts on the behalf of the patients. This independent committee will study the data and warn if the drug appears to be placing the volunteer at risk. Inclusion of this independent review committee in the drug trials will minimize the risks and maximizes the benefit. Using the unlicensed drugs or drugs prescribed to the adults would be only option if we stop clinical trial testing on the Children.

Tuesday 27 September 2011

Clinical Trial A Life Line For The People Suffering From The in Curable Diseases


Life is always a hope. Hope is the catalyst that runs the life when it is dumped in to the troubles. What if you are affected by the non curable disease that is killing your life? Do you like to stick to the bed depressed about reduced life span? you will rush to the hospital to find out a medication or source that keeps your life stay on the earth. 

If you are one suffering from the non curable diseases spending huge amount of money to increase your life expectancy, join the medical trial that is being conducted to treat your medical condition. I know lot many cases who regained their hopes about enjoying the life on the earth by participating in the clinical trials. If you are unsure about the results of the clinical trials, believe me, it is the life line for the people suffering from the diseases that finds no cure.

Medical trials are conducted with the intention to bring out the effective medicine, drug, surgery or procedure to find out the remedy for the health issue that is hampering the society.

What is the Informed consent all about?


Informed consent is medical document signed to provide the consent to the clinical trial. The document includes title of the research, purpose of the clinical trial, phases conducted in each trial and their objective. The informed consent should also detail about the producers that are carried out in the each trial and frequency of these procedure and place where they are conducted. The time length of the clinical trial  along with your right to quit the procedure at any point of time and any possible risks with the sudden withdrawal. 

The document also should notify the reader about the possible risks and benefits of the clinical trial to the volunteer. The document should mention about alternative options for the treatment if you deny undergoing the clinical trial. Costs and expenses incurred by your insurance company should be stated. Additional information that you should look into is the contact information to clarify your doubts further and the sources to get the additional information.

Monday 26 September 2011

Clinical Trial Vs Fair Market Value

Health sector is service industry and the interlinked pharmacy industry occupies the same branch. Do you think these two sectors are holding their hooks to the branches of the service sector? It is only permitted to the reading definition of the books. Practicality moved them far away from the service sector. They have turned out to be expensive and the increased clinical research costs stand as one of the main reasons behind the issue.


I believe there need for a constant and steady approach to cut down the costs of these clinical research and benefit three of them, the public, the investigator and pharmacy industry ( the sponsor) as well. 

Fair market value is defined accepted amount at which the seller is ready to sell and the buyer is ready to buy. This has to be achieved in every stage of the clinical trial process right from the investigator compensation to funding the resources. There are few clinical trial cost benchmarking companies to help the pharmacies to travel in the directed route and achieve the target.

Why is Fair Market Value Important?

Among two important heads of the clinical trial session, investigator occupies one end which is why his/her compensation becomes important in the budget of the clinical trial. Sound financial management system is necessary for the companies to run the clinical trials. This enables the sponsor companies to get most of their most value for their clinical grant spending. Sensible is what you require to get maximum out of less cost.


As the investigators are part of the vital clinical research process, I confirm that they should be carefully budgeted and perfectly evaluated. There are few important consideration to decide the fair market value in order to satisfy the investigators. Fair should be always decided on the amount of the work and the time spent in the laboratory to complete the task. The compensation you pay to the investigators turns to be the key factor in deciding the investigator attendance to the clinical research which in turn decides the success of the clinical trial. Far market value paid to the investigator decided the success of the Clinical trail project.

Fair Market Value for the Physicians

The investigators and the sponsors are the two ends in deciding the fair market value compensation in the clinical trial. How is this fair market value decided? Most of health care industries go by referral data provided in the market which is not a acceptable methodology or you should never go ahead with the going rate of the physician to decide the fair market value. The date provided in the market referrals should no longer be considered, this will increase the cost of your clinical trial rather. Establishing the compensation based on the few considerations will benefit in two ways, cutting down the time period of the clinical trial and reducing the expense by avoiding the duplicate costs.

A plat from should be set to understand the services provided, qualifications, and regulatory guide lines. Payments should be made based on measurable improvements in the quality of the work. All these should be documented ideally and need a continuous negotiations throughout the process. The medical affair services provided by the clinical trial cost management companies would from best plat form to conclude the fair market value compensation paid to the physician. They also render the services that are helpful in deciding the fair market value.

Fair Market Value in Clinical trials

The high sky pricing of clinical trial cost is now looking down for the fair market value. The clinical trial industry has traveled from the base costs. The time bound for them to realize the committed mistake has already exhausted. The increased competition among the sponsors to grab the expanding market has been the main driver behind the today’s changed scenarios. 


The increased cautiousness for the health, the growing diseases in the world are pouring profits into the pharmacy industry. Are these industries ruling the market? No, I sometimes awe that, in spite of finding great money flow into the industry, few of them still suffer from the loss because major slice of their profits is running in the form of investment in the clinical trials. The increased clinical costs have however increased the payments of the investigators which the sponsors are unable to afford. Absence of clinical costs in pharmacy industry will lose its existence in the market. Hope always leads the world into the future. There is still hope for the pharmacy industries to run in profits without compromising on the clinical trials. It is not that difficult as it sounds; get assistance from clinical trial costs bench marking companies that can help you in drawing fair market value in the shortest time possible by avoiding duplicate costs.